Solvay Pharmaceuticals says it plans to make a conditional tender offer to acquire the biotech company Innogenetics (Gent, Belgium) in a cash transaction valued at €5.75/share. Solvay initially entered into an R&D co-operation with Innogenetics in...
This information is only available to Chemical Week 24/7 members and subscribers.
Forgot your user ID or password? Click here to have it sent to you.
Not a Chemical Week
24/7 member yet? Here's why you
should be: Searchable online archive
access of the last 2 years
of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers